Patent · US Active

Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereof

US12209101B2 · kind B2 · utility

0Cited by
8References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2023
Grant dateJan 28, 2025
Priority date
Expiry dateAug 31, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/6584
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of anemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.